Gilead's Grip on HIV Medication: A Threat to Patient Access?
The recent appeals court ruling in favor of Gilead Sciences has reignited a heated debate about the role of pharmaceutical companies in controlling access to life saving medication.
On August 13, the US Court of Appeals for the Fourth Circuit upheld a preliminary injunction that blocks the importation or facilitation of foreign market Gilead branded HIV medications in the US.